זינט טבליות 125 מג Israel - hebraisk - Ministry of Health

זינט טבליות 125 מג

novartis israel ltd., israel - cefuroxime as axetil - טבליה - cefuroxime as axetil 125 mg - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible micro-organisms.

זינט טבליות 250 מג Israel - hebraisk - Ministry of Health

זינט טבליות 250 מג

novartis israel ltd., israel - cefuroxime as axetil - טבליה - cefuroxime as axetil 250 mg - cefuroxime - cefuroxime - treatment of infections due to cefuroxime susceptible microorganisms.

זינט טבליות 500 מג Israel - hebraisk - Ministry of Health

זינט טבליות 500 מג

novartis israel ltd., israel - cefuroxime as axetil - טבליה - cefuroxime as axetil 500 mg - cefuroxime

צפואבניר 250 מג Israel - hebraisk - Ministry of Health

צפואבניר 250 מג

bioavenir ltd, israel - cefuroxime as axetil - טבליה - cefuroxime as axetil 250 mg - cefuroxime

צפואבניר 500 מג Israel - hebraisk - Ministry of Health

צפואבניר 500 מג

bioavenir ltd, israel - cefuroxime as axetil - טבליה - cefuroxime as axetil 500 mg - cefuroxime

טיפטיפות אפלפי Israel - hebraisk - Ministry of Health

טיפטיפות אפלפי

cts chemical industries ltd, israel - pseudoephedrine as hydrochloride - טיפות - pseudoephedrine as hydrochloride 15 mg/ml - pseudoephedrine - pseudoephedrine - symptomatic treatment of nasal congestion, to relief eustachian tube congestion.

סטאלבו   10025200 מג Israel - hebraisk - Ministry of Health

סטאלבו 10025200 מג

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 100 mg; carbidopa 25 mg; entacapone 200 mg - levodopa - levodopa - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.

סטאלבו   5012.5200 מג Israel - hebraisk - Ministry of Health

סטאלבו 5012.5200 מג

inovamed pharma ltd, israel - carbidopa; entacapone; levodopa - טבליות מצופות פילם - levodopa 50 mg; carbidopa 12.5 mg; entacapone 200 mg - levodopa and decarboxylase inhibitor - levodopa and decarboxylase inhibitor - treatment of patients with parkinson's disease and end-of-dose motor fluctuations not stabilised on levodopa/dopa decarboxylase (ddc) inhibitor treatment.